• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCH446211(SCH6)的发现:一种新型的丙型肝炎病毒NS3丝氨酸蛋白酶和丙型肝炎病毒亚基因组RNA复制的酮酰胺抑制剂。

Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication.

作者信息

Bogen Stéphane L, Arasappan Ashok, Bennett Frank, Chen Kevin, Jao Edwin, Liu Yi-Tsung, Lovey Raymond G, Venkatraman Srikanth, Pan Weidong, Parekh Tajel, Pike Russel E, Ruan Sumei, Liu Rong, Baroudy Bahige, Agrawal Sony, Chase Robert, Ingravallo Paul, Pichardo John, Prongay Andrew, Brisson Jean-Marc, Hsieh Tony Y, Cheng Kuo-Chi, Kemp Scott J, Levy Odile E, Lim-Wilby Marguerita, Tamura Susan Y, Saksena Anil K, Girijavallabhan Viyyoor, Njoroge F George

机构信息

Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, USA.

出版信息

J Med Chem. 2006 May 4;49(9):2750-7. doi: 10.1021/jm060077j.

DOI:10.1021/jm060077j
PMID:16640336
Abstract

Introduction of various modified prolines at P(2) and optimization of the P(1) side chain led to the discovery of SCH6 (24, Table 2), a potent ketoamide inhibitor of the HCV NS3 serine protease. In addition to excellent enzyme potency (K(i)*= 3.8 nM), 24 was also found to be a potent inhibitor of HCV subgenomic RNA replication with IC(50) and IC(90) of 40 and 100 nM, respectively. Recently, antiviral activity of 24 was demonstrated with inhibition of the full-length genotype 2a HCV genome. In addition, 24 was found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containing HCV RNA replicons.

摘要

在P(2)位点引入各种修饰脯氨酸并优化P(1)侧链,从而发现了SCH6(24,表2),一种有效的丙型肝炎病毒NS3丝氨酸蛋白酶酮酰胺抑制剂。除了具有出色的酶活性(K(i)* = 3.8 nM)外,24还被发现是丙型肝炎病毒亚基因组RNA复制的有效抑制剂,其IC(50)和IC(90)分别为40和100 nM。最近,通过抑制全长2a基因型丙型肝炎病毒基因组证明了24的抗病毒活性。此外,发现24可恢复含有丙型肝炎病毒RNA复制子的细胞中干扰素调节因子3(IRF-3)的反应性。

相似文献

1
Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication.SCH446211(SCH6)的发现:一种新型的丙型肝炎病毒NS3丝氨酸蛋白酶和丙型肝炎病毒亚基因组RNA复制的酮酰胺抑制剂。
J Med Chem. 2006 May 4;49(9):2750-7. doi: 10.1021/jm060077j.
2
Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profiles.关于波普瑞韦(SCH 503034)的后备研究:新型P4端延长的丙型肝炎病毒NS3丝氨酸蛋白酶酮酰胺抑制剂的发现,其活性和药代动力学特性得到改善
J Med Chem. 2009 Jun 25;52(12):3679-88. doi: 10.1021/jm801632a.
3
In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.丙肝病毒NS3丝氨酸蛋白酶新型抑制剂SCH446211(SCH6)的体外抗病毒活性
J Antimicrob Chemother. 2007 Jan;59(1):51-8. doi: 10.1093/jac/dkl455. Epub 2006 Dec 5.
4
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.源自脯氨酸基大环化合物的新型强效丙型肝炎病毒NS3丝氨酸蛋白酶抑制剂。
J Med Chem. 2006 Feb 9;49(3):995-1005. doi: 10.1021/jm050820s.
5
Depeptidization efforts on P3-P2' alpha-ketoamide inhibitors of HCV NS3-4A serine protease: effect on HCV replicon activity.针对丙型肝炎病毒NS3-4A丝氨酸蛋白酶的P3-P2'α-酮酰胺抑制剂的去肽化研究:对丙型肝炎病毒复制子活性的影响
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1621-7. doi: 10.1016/j.bmcl.2005.12.013. Epub 2006 Jan 4.
6
Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical species.发现具有强大的磺胺 P4-封端酮酰胺结构的第二代丙型肝炎病毒 NS3 丝氨酸蛋白酶抑制剂,在临床前物种中具有良好的药代动力学特征。
Bioorg Med Chem. 2010 Mar 1;18(5):1854-65. doi: 10.1016/j.bmc.2010.01.044. Epub 2010 Jan 25.
7
The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.丙型肝炎病毒NS3蛋白酶强效抑制剂的设计:BILN 2061——从核磁共振管到临床应用
Biopolymers. 2004;76(4):309-23. doi: 10.1002/bip.20127.
8
Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.在人细胞中表达的膜相关丙型肝炎病毒NS3-4A异源复合丝氨酸蛋白酶活性的酶学特性分析
Biochemistry. 2005 May 3;44(17):6586-96. doi: 10.1021/bi047408j.
9
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization.丙型肝炎病毒NS3.4A蛋白酶抑制剂2.弹头的构效关系及优化
Bioorg Med Chem Lett. 2004 Mar 22;14(6):1441-6. doi: 10.1016/j.bmcl.2004.01.022.
10
Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.丙型肝炎病毒丝氨酸蛋白酶对干扰素调节因子-3的调控
Science. 2003 May 16;300(5622):1145-8. doi: 10.1126/science.1082604. Epub 2003 Apr 17.

引用本文的文献

1
Fixing the Achilles Heel of Pfizer's Paxlovid for COVID-19 Treatment.解决辉瑞 COVID-19 治疗药物 Paxlovid 的阿喀琉斯之踵。
J Med Chem. 2024 Jul 25;67(14):11656-11661. doi: 10.1021/acs.jmedchem.4c01342. Epub 2024 Jul 5.
2
Exploring theophylline-1,2,4-triazole tethered -phenylacetamide derivatives as antimicrobial agents: unraveling mechanisms via structure-activity relationship, validation, and insights.探索茶碱-1,2,4-三唑连接的苯乙酰胺衍生物作为抗菌剂:通过构效关系、验证和深入分析揭示作用机制
Front Chem. 2024 Apr 5;12:1372378. doi: 10.3389/fchem.2024.1372378. eCollection 2024.
3
Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 Months.
在17个月内开发出奈玛特韦的商业化生产工艺。
ACS Cent Sci. 2023 Mar 29;9(5):849-857. doi: 10.1021/acscentsci.3c00145. eCollection 2023 May 24.
4
Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease.基因型 3 丙型肝炎 NS3/4A 蛋白酶耐药性的分子和动态机制。
J Am Chem Soc. 2016 Sep 14;138(36):11850-9. doi: 10.1021/jacs.6b06454. Epub 2016 Sep 2.
5
The Discovery and Development of Boceprevir: A Novel, First-generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease.博赛泼维的发现与研制:一种新型第一代丙型肝炎病毒 NS3/4A 丝氨酸蛋白酶抑制剂。
J Clin Transl Hepatol. 2013 Sep;1(1):22-32. doi: 10.14218/JCTH.2013.002XX. Epub 2013 Sep 15.
6
Role of Marine Natural Products in the Genesis of Antiviral Agents.海洋天然产物在抗病毒药物起源中的作用。
Chem Rev. 2015 Sep 23;115(18):9655-706. doi: 10.1021/cr4006318. Epub 2015 Aug 28.
7
Organic carbamates in drug design and medicinal chemistry.药物设计与药物化学中的有机氨基甲酸酯
J Med Chem. 2015 Apr 9;58(7):2895-940. doi: 10.1021/jm501371s. Epub 2015 Jan 7.
8
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus.导致丙型肝炎病毒 NS3-4A 蛋白酶 V36 和 T54 突变的特拉匹韦耐药的分子基础。
Genome Biol. 2008 Jan 23;9(1):R16. doi: 10.1186/gb-2008-9-1-r16.
9
Modulation of host metabolism as a target of new antivirals.调节宿主代谢作为新型抗病毒药物的靶点。
Adv Drug Deliv Rev. 2007 Oct 10;59(12):1277-89. doi: 10.1016/j.addr.2007.03.021. Epub 2007 Aug 11.
10
Controversies in and challenges to our understanding of hepatitis C.我们对丙型肝炎理解中的争议与挑战。
World J Gastroenterol. 2007 Aug 21;13(31):4168-76. doi: 10.3748/wjg.v13.i31.4168.